Skip to main navigation
 homepage
  • About
  • Science
    • How It Works
    • Our Pipeline
    • Publications
  • Patients
    • Our Commitment To Patients
    • Generalized Myasthenia Gravis
    • Sjögren’s Disease (SD)
  • Careers
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • Analyst Coverage
    • Corporate Governance
    • SEC Filings
    • Stock Quote & Chart
    • Contact IR
    • Email Alerts
    • Tax Information
  • Contact

Events & Presentations

Investor Presentations

Vor Bio Corporate Presentation September 2026

Upcoming Events

No Upcoming Events to display

Archived Events

Stifel’s 2026 Virtual Immunology and Inflammation Forum
Sep 23, 2026 11:30 AM EDT
Click Here for Webcast
Baird’s 2026 Global Healthcare Conference
Sep 15, 2026 9:05 AM EDT
Morgan Stanley 24th Annual Global Healthcare Conference
Sep 14, 2026
Citi’s 2026 Biopharma Back to School Conference
Sep 9, 2026 11:20 AM EDT
Click Here for Webcast
Wells Fargo 21st Annual Healthcare Conference
Sep 8, 2026 8:00 AM EDT
Click Here for Webcast
Vor Bio homepage
  • About
  • Science
    • How It Works
    • Our Pipeline
    • Publications
  • Patients
    • Our Commitment To Patients
    • Myasthenia Gravis
    • Sjögren’s Disease (SD)
  • Careers
  • Investors
    • News Releases
    • Events & Presentations
    • Analyst Coverage
    • Corporate Governance
    • SEC Filings
    • Tax Information
    • Stock Quote & Chart
    • Contact IR
    • Email Alerts
  • Contact

© 2026 Vor Bio | Telitacicept is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA).

  • Privacy Policy
  • Terms of Use